Primary Site >> Pancreatic Cancer

Gene >> ERBB4

Journal: J Gastrointest Surg. 2004 Dec;8(8):960-9; discussion 969-70.
Title: Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.
Author: Arnoletti, J Pablo|Buchsbaum, Donald J|Huang, Zhi-qiang|Hawkins, Ashley E|Khazaeli, Muhamad B|Kraus, Matthias H|Vickers, Selwyn M
PMID: 15585383
Journal:
Title: [(11)C]N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
Author: Shan, Liang
PMID: 20641864
Journal: J Med Chem. 2006 Feb 23;49(4):1475-85.
Title: Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors.
Author: Klutchko, Sylvester R|Zhou, Hairong|Winters, R Thomas|Tran, Tuan P|Bridges, Alexander J|Althaus, Irene W|Amato, Danielle M|Elliott, William L|Ellis, Paul A|Meade, Mary Ann|Roberts, Billy J|Fry, David W|Gonzales, Andrea J|Harvey, Patricia J|Nelson, James M
PMID: 16480284
Journal: Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G434-41.
Title: Epidermal growth factor receptor regulates pancreatic fibrosis.
Author: Blaine, Stacy A|Ray, Kevin C|Branch, Kevin M|Robinson, Pamela S|Whitehead, Robert H|Means, Anna L
PMID: 19608732
Journal: Clin Cancer Res. 2010 Feb 1;16(3):912-23.
Title: Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.
Author: Kimple, Randall J|Vaseva, Angelina V|Cox, Adrienne D|Baerman, Kathryn M|Calvo, Benjamin F|Tepper, Joel E|Shields, Janiel M|Sartor, Carolyn I
PMID: 20103665
Journal: Exp Cell Res. 2011 Feb 15;317(4):392-404.
Title: Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
Author: Mill, Christopher P|Gettinger, Kathleen L|Riese, David J 2nd
PMID: 21110957
Journal: Curr Drug Targets. 2012 Jun;13(6):802-10.
Title: Targeting EGFR in pancreatic cancer treatment.
Author: Troiani, T|Martinelli, E|Capasso, A|Morgillo, F|Orditura, Michele|De Vita, F|Ciardiello, F
PMID: 22458527
Journal: J Cancer Res Ther Oncol. 2013 Aug 22;1(1):10.
Title: Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant.
Author: Gallo, Richard M|Bryant, Ianthe N|Mill, Christopher P|Kaverman, Steven|Riese, David J 2nd
PMID: 24791013
Journal: Pharmacol Res. 2014 Jan;79:34-74.
Title: The ErbB/HER family of protein-tyrosine kinases and cancer.
Author: Roskoski, Robert Jr
PMID: 24269963
Journal: Naunyn Schmiedebergs Arch Pharmacol. 2014 Jun;387(6):505-21.
Title: A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer.
Author: Modjtahedi, Helmout|Cho, Byoung Chul|Michel, Martin C|Solca, Flavio
PMID: 24643470
Journal: Cancer Lett. 2016 Sep 28;380(1):98-105.
Title: The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway.
Author: Chen, Yiwen|Bai, Xueli|Zhang, Qi|Wen, Liang|Su, Wei|Fu, Qihan|Sun, Xu|Lou, Yu|Yang, Jiaqi|Zhang, Jingying|Chen, Qi|Wang, Jianxin|Liang, Tingbo
PMID: 27339327
Journal: BMC Cancer. 2016 Nov 21;16(1):910.
Title: The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.
Author: Li, Qin|Zhang, Lei|Li, XiuHong|Yan, Han|Yang, Liuting|Li, Yingying|Li, Teng|Wang, Jing|Cao, Bangwei
PMID: 27871278